CompaniesAerium Therapeutics

Aerium Therapeutics

defunct

About

Defunct Company

Areas of Focus

Categories

Bankrupt, Merged, Sold, Renamed or Otherwise Defunct

Clinical Trials (1)

Total Trials

1

As Lead Sponsor

0

As Collaborator

1

Total Enrollment

36

By Phase

PHASE2: 1

By Status

ACTIVE_NOT_RECRUITING: 1

Clinical Trials Pipeline1 trial

Early Phase 1

Phase 1

Phase 2

Phase 3

Phase 4

Phase 1/2

Phase 2/3

N/A

Phase

Status

Role

Condition

2022

2023

2024

2025

2026

Today

Hover over trial bars to see details

Recent Trials

NCT05877508Collaborator

Anti-SARS-CoV-2 Monoclonal Antibodies for Long COVID (COVID-19)

PHASE2Active, not recruiting

36 participants

Started: Aug 1, 2023 · Completed: Jul 31, 2025